Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Weight-loss drugs didn't curb health costs within two years
Weight-loss drugs didn't curb health costs within two years
Weight-loss drugs didn't curb health costs within two years
Submitted by
admin
on October 24, 2024 - 11:11am
Source:
Reuters
News Tags:
Novo Nordisk
Eli Lilly
Wegovy
Zepbound
obesity
Headline:
Weight-loss drugs didn't curb health costs within two years
snippet:
Costs rose 46% over two years for patients trying GLP-1 drugs for obesity
Obesity treatment did not reduce other medical costs, data show
Only one in four patients were still on Wegovy or Ozempic two years later
Do Not Allow Advertisers to Use My Personal information